VRTXVertex Pharmaceuticals

$547.27

Who owns VRTX

1,634 institutions reported holding VRTX for 2026Q1, together 90% of the company, more than the 1,623 a quarter earlier.

1,634

Institutions reporting a position · as of 2026Q1 · up from 1,623 the quarter before

Shares held by institutions
231.1M

Shares held by institutions · 90% of the company · long US equity positions only, as reported on Form 13F

Reported value
$103.1B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
42%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
52
New positions
141
Positions exited
133
Added to
601
Reduced
551
Top 10 holdersof the company
52%
Institutional ownership by quarter, 2013Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q11,634231.1M$103.1B
2025Q41,623235.0M$106.5B
2025Q31,485231.2M$90.4B
2025Q21,520239.8M$106.7B
2025Q11,574238.9M$115.8B
2024Q41,525235.5M$94.8B
2024Q31,514233.5M$108.4B
2024Q21,522233.8M$109.2B
2024Q11,460234.7M$97.5B
2023Q41,410234.2M$95.0B
2023Q31,256234.2M$81.2B
2023Q21,261236.7M$82.9B
2023Q11,186238.8M$74.6B
2022Q41,198236.1M$68.0B
2022Q31,105236.3M$68.2B
2022Q21,088233.9M$65.6B
Largest reported holders, 2026Q1
HolderShares% of companyValue
Capital World Investors25.4M9.9%$11.3B
VANGUARD GROUP INC24.3M9.5%$10.8B
BlackRock Inc.24.0M9.4%$10.7B
Capital Research Global Investors21.1M8.2%$9.43B
STATE STREET CORP11.7M4.6%$5.24B
JPMORGAN CHASE & CO7.0M2.7%$3.12B
GEODE CAPITAL MANAGEMENT LLC6.1M2.4%$2.73B
Capital International Investors5.1M2.0%$2.29B
LOOMIS SAYLES & CO L P4.0M1.6%$1.79B
ALLIANCEBERNSTEIN L.P.3.9M1.5%$1.77B

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…